Cantel Medical Reports Results for First Quarter Ended October 31, 2016

Cantel Medical (NYSE:CMD) today reports its financial results for the first quarter, which ended on October 31 of this year.
According to the press release:

“[Cantel] reported record US GAAP net income of $18,800,000, or $0.45 per diluted share, on a 22.1% increase in sales to a record $187,725,000 for the first quarter ended October 31, 2016. This compares with net income of $14,254,000, or $0.34 per diluted share, on sales of $153,779,000 for the first quarter ended October 31, 2015.”

CEO Jorgen B. Hansen said the following:

“All three of our major business segments had strong performance in the first quarter. Our continued investments in new product development, commercial programs as well as the integration of recent acquisitions continue to drive our growth. These investments have helped us achieve double-digit organic sales growth in 11 of the past 13 quarters.”

Read the full press release here.